• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂 B7 突变导致 Nagashima 型掌跖角化病及其在斑马鱼中的时空表达。

SERPINB7 mutation causes Nagashima-type palmoplantar keratosis and its spatiotemporal expression in zebrafish.

机构信息

Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Veneorology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

Hangzhou Normal University, Hangzhou, China.

出版信息

Exp Dermatol. 2023 Jun;32(6):766-776. doi: 10.1111/exd.14762. Epub 2023 Feb 20.

DOI:10.1111/exd.14762
PMID:36772997
Abstract

Serine protease inhibitor B7 (SERPINB7) mutations have been reported to cause Nagashima-type palmoplantar keratosis (NPPK), but their biological effects are largely unknown. We conducted whole-exome sequencing and identified a c.796C>T (p.Arg266Ter) mutation in SERPINB7 in a Chinese pedigree, which presented as an autosomal recessive inheritance pattern. We assessed the function of SERPINB7 in homozygous and heterozygous mutation carriers, and the results suggested that the single c.796C>T mutation may alter the subcellular localization of SERPINB7. One of the homozygous mutation patients (II-3) was treated with ixekizumab and showed moderate improvement in keratinization. In addition, we analysed the spatiotemporal expression of serpinb1l1 and serpinb1l3, the zebrafish homologue of human SERPINB7, which is expressed in larvae and adults. In larvae, both serpinb1l1 and serpinb1l3 were expressed in the digestive tract. Then, we performed RT-PCR on adult fins based on similarity to the site of NPPK expression in humans and found that the genes were expressed in five fins (pectoral, pelvic, dorsal, anal and caudal) of the zebrafish distal extremity. Taken together, our results demonstrated that the single c.796C>T (p.Arg266Ter) mutation may alter the location of SERPINB7-encoded protein in the skin, while zebrafish SERPINB7 homologue was expressed in adult fins. These findings will enable us to construct knock-out models to explore the pathogenesis of palmoplantar keratosis.

摘要

丝氨酸蛋白酶抑制剂 B7 (SERPINB7) 突变已被报道可导致 Nagashima 型掌跖角化病 (NPPK),但其生物学效应在很大程度上尚不清楚。我们进行了全外显子组测序,在一个中国家系中发现了 SERPINB7 的 c.796C>T (p.Arg266Ter) 突变,呈常染色体隐性遗传模式。我们评估了 SERPINB7 在纯合和杂合突变携带者中的功能,结果表明单个 c.796C>T 突变可能改变 SERPINB7 的亚细胞定位。一位纯合突变患者 (II-3) 接受了 ixekizumab 治疗,角化改善程度为中度。此外,我们分析了丝氨酸蛋白酶抑制剂 B1L1 和丝氨酸蛋白酶抑制剂 B1L3 的时空表达,丝氨酸蛋白酶抑制剂 B1L3 是人类 SERPINB7 的斑马鱼同源物,在幼虫和成年期表达。在幼虫中,serpinb1l1 和 serpinb1l3 在消化道中均有表达。然后,我们根据与人类 NPPK 表达部位的相似性,在成年鱼鳍上进行 RT-PCR,发现该基因在鱼鳍的五个部位(胸鳍、腹鳍、背鳍、臀鳍和尾鳍)表达。总之,我们的研究结果表明,单个 c.796C>T (p.Arg266Ter) 突变可能改变 SERPINB7 编码蛋白在皮肤中的位置,而斑马鱼 SERPINB7 同源物在成年鱼鳍中表达。这些发现将使我们能够构建敲除模型,以探索掌跖角化病的发病机制。

相似文献

1
SERPINB7 mutation causes Nagashima-type palmoplantar keratosis and its spatiotemporal expression in zebrafish.丝氨酸蛋白酶抑制剂 B7 突变导致 Nagashima 型掌跖角化病及其在斑马鱼中的时空表达。
Exp Dermatol. 2023 Jun;32(6):766-776. doi: 10.1111/exd.14762. Epub 2023 Feb 20.
2
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.丝氨酸蛋白酶抑制剂超家族成员 SERPINB7 的突变导致 Nagashima 型掌跖角化病。
Am J Hum Genet. 2013 Nov 7;93(5):945-56. doi: 10.1016/j.ajhg.2013.09.015. Epub 2013 Oct 24.
3
Highly prevalent SERPINB7 founder mutation causes pseudodominant inheritance pattern in Nagashima-type palmoplantar keratosis.高度流行的丝氨酸蛋白酶抑制剂 B7 种系突变导致 Nagashima 型掌跖角化病的拟显性遗传模式。
Br J Dermatol. 2014 Oct;171(4):847-53. doi: 10.1111/bjd.13076. Epub 2014 Sep 22.
4
Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.在中国人群的 Nagashima 型掌跖角化病的 8 个病例中发现了 SERPINB7 的两个新突变。
J Dermatol. 2022 May;49(5):539-544. doi: 10.1111/1346-8138.16310. Epub 2022 Feb 17.
5
Nagashima-type palmoplantar keratosis in a Chinese Han population.中国汉族人群中的长岛型掌跖角化病。
Mol Med Rep. 2016 Nov;14(5):4049-4054. doi: 10.3892/mmr.2016.5757. Epub 2016 Sep 21.
6
Gentamicin-Induced Readthrough and Nonsense-Mediated mRNA Decay of SERPINB7 Nonsense Mutant Transcripts.庆大霉素诱导的 SERPINB7 无义突变转录本通读和无义介导的 mRNA 衰变。
J Invest Dermatol. 2018 Apr;138(4):836-843. doi: 10.1016/j.jid.2017.10.014. Epub 2017 Oct 26.
7
Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency.长岛型掌跖角化病:一种由丝氨酸蛋白酶抑制剂B7缺乏引起的常见亚洲型疾病。
J Invest Dermatol. 2014 Aug;134(8):2076-2079. doi: 10.1038/jid.2014.156.
8
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.中国 Nagashima 型掌跖角化病的调查:234 例患者的横断面研究。
J Dermatol. 2023 Mar;50(3):375-382. doi: 10.1111/1346-8138.16621. Epub 2022 Nov 1.
9
Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7.伴有丝氨酸蛋白酶抑制剂B7基因复合杂合突变的长岛型掌跖角化病
Case Rep Dermatol. 2020 Nov 17;12(3):241-248. doi: 10.1159/000509535. eCollection 2020 Sep-Dec.
10
Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.Nagashima 型掌跖角化病:临床特征、遗传特征及临床管理。
Biomed Res Int. 2021 Jan 27;2021:8841994. doi: 10.1155/2021/8841994. eCollection 2021.